We had no shortage of blood pressure medication recalls in 2018, with multiple companies issuing warnings over drug impurities that could cause cancer. It looks like that trend will continue in 2019 as yet another company has issued a recall of blood pressure tablets after detecting an impurity that may be cancer-causing.
This time around it’s Aurobindo Pharma USA Inc, which is recalling prescriptions of the drug Valsartan. Valsartan, you may remember, has been the subject of recalls due to such impurities in the past. The drug is sold by several manufacturers, and in July of 2018 almost a half-dozen companies were forced to recall their products due to the discovery of human carcinogens in the tablets.
BGR Top Deals:
- This $80 smartwatch with a 30-day battery outsold every holiday wearable deal, and now it’s back
- This best-selling Chromebook has a coveted ‘Amazon’s Choice’ designation and it’s under $250
Trending Right Now:
- New ‘Avengers: Endgame’ theory says Marvel has been misleading us for years
- Galaxy S10’s most exciting new feature might be battery tech no other Android or iPhone has
- Apple’s unreleased iOS 13 software was just spotted for the first time, and we can’t wait
Another blood pressure medication has been recalled over cancer-causing impurity originally appeared on BGR.com on Thu, 3 Jan 2019 at 12:30:08 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report